109048 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
Antisense compositions and methods of making and using same
#9602COLON DISEASE TARGETS AND USES THEREOF
#9603Methods and compositions for the treatment of insulin-associated medical conditions
#9604MICROPEPTIDES AND USE THEREOF FOR MODULATING GENE EXPRESSION
#9605OVULE SPECIFIC PROMOTER AND METHODS OF USE
#9606Synthesis of deuterated ribo nucleosides, N-protected phosphoramidites, and oligonucleotides
#9607Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8
#9608Compositions for use in treating or diagnosing bone disorders and/or cardiovascular disorders
#9609Methods and compositions for modulating MIR-204 activity
#9610RNA products and uses thereof
#9611CUL4B as predictive biomarker for cancer treatment
#9612Nucleic acid fragment binding to target protein
#9613Oligonucleotide, glucocorticoid sensitivity enhancer, pharmaceutical composition, and expression vector
#9614Method for constructing functional nucleic acid molecule, and nucleic acid combination to be used in said method
#9615Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules
#9616Amphoteric Liposome Formulation
#9617Lipid nanoparticle compositions and methods of making and methods of using the same
#9618Methods and Compositions for Manipulating the Immune System
#9619Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
#9620Methods and compositions for root knot nematode control
#9621ISOLATED NOVEL NUCLEIC ACID AND PROTEIN MOLECULES FROM CORN AND METHODS OF USING THOSE MOLECULES TO GENERATE TRANSGENIC PLANTS WITH ENHANCED AGRONOMIC TRAITS
#9622Sequence-determined DNA fragments with regulatory functions
#9623Method for treating glioma using Tarbp2 expression inhibitor
#9624Methods for the treatment of leber congenital amaurosis
#9625Treatment of cancers with micro-RNA inhibitors
#9626RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor
#9627Methods for delivery to the central nervous system of nucleic acid nanoparticles to treat central nervous system disorders
#9628Compositions and methods for inhibiting expression of the ALAS1 gene
#9629Cancer therapeutics
#9630Composition for gene delivery
#9631Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
#9632COMPOSITIONS COMPRISING MG53 AND METHODS FOR THE TREATMENT AND PREVENTION OF AIRWAY INJURY
#9633Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
#9634regulatory elements and uses thereof
#9635regulatory elements and uses thereof
#9636Interfering RNA molecules
#9637Polynucleotide comprising sequences of wheat gliadins and use thereof for silencing by RNAi
#9638Multi-targeting short interfering RNAs
#9639MicroRNA compounds and methods for modulating miR-122
#9640Fidgetin-like 2 as a target to enhance wound healing
#9641RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
#9642Antisense compounds targeting genes associated with fibronectin
#9643Single-stranded nucleic acid molecule for regulating expression of gene having delivering function
#9644Nucleic Acid Molecule Capable of Inhibiting Expression of Periostin Gene, method for Inhibiting Expression of Periostin Gene, and Use of Said Nucleic Acid Molecule
#9645LIM kinasemodulating agents for neurofibromatoses therapy and methods for screening for same
#9646ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION
#9647Small activating RNA molecules and methods of use
#9648MiRNA-31 AS A DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC AGENT IN CANCER
#9649Compositions and methods for gene silencing
#9650GNAQ targeted dsRNA compositions and methods for inhibiting expression
#9651Rational design of microRNA-siRNA chimeras for multi-functional target suppression
#9652Compositions and methods for modulating UTRN expression
#9653COMPOSITIONS AND METHODS FOR MODULATING MITOCHONDRIAL PYRUVATE CARRIER ACTIVITY
#9654Compositions and methods for silencing gene expression
#9655Method of regulating gene expression
#9656RNA-interference by single-stranded RNA molecules
#9657OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN MODULATION OF SMALL NON-CODING RNAS
#9658Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF
#9659Methods for Differentiating Pancreatic Cancer from Normal Pancreatic Function and/or Chronic Pancreatitis
#9660Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to DMD family
#9661Modulation of NLGn4 expression, NK cell activity in non-alcoholic fatty liver disease (NAFLD)
#9662NUCLEOTIDES FOR PREVENTION AND TREATMENT OF BACTERIAL AND FUNGAL PATHOLOGIES
#9663METHODS AND COMPOSITIONS FOR INHIBITING THE FUNCTION OF POLYNUCLEOTIDE SEQUENCES
#9664Block copolymer, liquid composite thereof, nucleic acid preparation, preparation methods therefor, and use thereof
#9665METHOD OF CONTROLLING INITIAL DRUG RELEASE OF siRNA FROM SUSTAINED-RELEASE IMPLANTS
#9666Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO
#9667MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS
#9668Micro-RNAs involved in macular degeneration
#9669Methods and compositions for modulating alpha-1-antitrypsin expression
#9670COMPOSITIONS AND METHODS FOR EFFICACIOUS AND SAFE DELIVERY OF siRNA USING SPECIFIC CHITOSAN-BASED NANOCOMPLEXES
#9671MICRORNA COMPOSITIONS AND METHODS
#9672Peptide-conjugated oligonucleotide therapeutic and method of making and using same
#9673Device and method for analyzing streptavidin
#9674Glycaspis Brimblecombei Control Agents
#9675Bronze bug control agents
#9676Synthesis and uses of nucleic acid compounds with conformationally restricted monomers
#96775′ phosphate mimics
#9678Treatment of nuclear respiratory factor 1 (NRF1) related diseases by inhibition of natural antisense transcript to NRF1
#9679Treatment of transcription factor E3 (TFE3) and insulin receptor substrate 2 (IRS2) related diseases by inhibition of natural antisense transcript to TFE3
#9680Targeting micrornas for the treatment of fibrosis
#9681Compositions and methods related to protein displacement therapy for myotonic distrophy
#9682Boronic acid conjugates of oligonucleotide analogues
#9683MULTI-TARGET MODULATION FOR TREATING FIBROSIS AND INFLAMMATORY CONDITIONS
#9684Spalt-like transcription factor 4 (SALL4) and uses thereof
#9685Compound and method for treating myotonic dystrophy
#9686CRISPR-Cas component systems, methods and compositions for sequence manipulation
#9687MicroRNA Treatment for Asthma
#9688ANTI-NEOPLASTIC USES OF ARTEMIN ANTAGONISTS
#9689STEM CELL MICROPARTICLES
#9690iRNA agents with biocleavable tethers
#9691Micro-RMA inhibitor
#9692Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
#9693Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRNA
#9694Methods and pharmaceutical compositions for the treatment of hypertension
#96952′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and use
#9696LM-antibodies, functional fragments, LM-1 target antigen, and methods for making and using same
#9697Combination therapy using c-Met inhibitor and beta-catenin inhibitor
#9698Extended DNA-sensing GRNAS
#9699MRNA-sensing switchable gRNAs
#9700Switchable gRNAs comprising aptamers
#9701Functionalized fluorine containing phthalocyanine molecules
#9702Glycoconjugates of RNA interference agents
#9703Methods for controlling pests using RNAi
#9704THERAPEUTIC TARGETS FOR MITOCHONDRIAL DISORDERS
#9705Methods and compositions for the specific inhibition of MCL1 by double-stranded RNA
#9706Neurofibromatoses therapeutic agents and screening for same
#9707Visfatin therapeutic agents for the treatment of acne and other conditions
#9708REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#9709Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
#9710Trialkyl cationic lipids and methods of use thereof
#9711MEDICINAL COMPOSITION FOR TREATING INFARCTION
#9712Diether based biodegradable cationic lipids for siRNA delivery
#9713Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene
#9714Double-stranded oligonucleotides
#9715Methods for the treatment of nonalcoholic steatohepatitis
#9716ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF
#9717COMPOUNDS AND METHODS FOR MODULATING EXPRESSION APOB
#9718HIGH THROUGHPUT METHODS FOR FUNCTIONALLY DETERMINING RNA INTERFERENCE EFFICIENCY
#9719DNA controlling miR-140 expression, and screening method of drugs using said DNA
#9720SELF-CLEAVING RIBOZYMES AND USES THEREOF
#9721Compositions and methods for insecticidal control of stinkbugs
#9722SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF
#9723Identification of a JAK2 mutation in polycythemia vera
#9724Technology for the Preparation of Microparticles
#9725RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
#9726Reverse micelle system comprising nucleic acids and use thereof
#9727Methods and compositions for RNAi-based cancer treatment
#9728Methods for treating eye disorders
#9729Treatment of TH17-Mediated Autoimmune Disease Via Inhibition of Stat3
#9730Combination therapy for cancer using HSP27 inhibitor and EGFR tyrosine kinase inhibitors or anti-folates
#9731ANTI-MCPIP THERAPIES FOR OCULAR NEOVASCULARIZATION
#9732INHIBITING GENE EXPRESSION WITH dsRNA
#9733Delivery of dsRNA to arthropods
#9734RNA-directed DNA cleavage by the Cas9-crRNA complex
#9735Trans-acting RNA switches
#9736RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Duchenne and Becker Muscular Dystrophy
#9737Use of the chromosome 19 microRNA cluster (C19MC) for treating viral disease and promoting authophagy
#9738Pain treatment
#9739METHOD OF REGULATING CFTR EXPRESSION AND PROCESSING
#9740IDENTIFICATION OF A NOVEL BHD GENE
#9741METHOD FOR IDENTIFYING DISEASE ASSOCIATED WITH ABUNDANCE OF TDP-43 IN CELL
#9742METHOD FOR IDENTIFICATION OF THE SEQUENCE OF POLY(A)+RNA THAT PHYSICALLY INTERACTS WITH PROTEIN
#9743Compositions and Methods for Diagnosing, Preventing and Treating Intracranial Aneurysms
#9744Method of enhancing the efficacy of anti-hepatocyte growth factor receptor breast cancer therapy by administering an inhibitor of mena
#9745Compositions for Inhibiting Gene Expression and Uses Thereof
#9746β-actin and RPS21 promoters and uses thereof
#9747Extended dicer substrate agents and methods for the specific inhibition of gene expression
#9748Extended dicer substrate agents and methods for the specific inhibition of gene expression
#9749Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1
#9750Targeting MicroRNAs for metabolic disorders
#9751Methods and Compositions for Modulating Gene Expression Using Components That Self Assemble in Cells and Produce RNAi Activity
#9752Use of miR-23a-3p and/or miR-27a-3p mimics as therapeutic agents for inhibition of neuronal apoptosis following brain injury
#9753siRNA compositions and methods for inhibiting gene expression in tumor initiating cells of breast cancer
#9754ROBO2 inhibitory compositions comprising SLIT2-binding extracellular domain of ROBO2
#9755Generation of neural stem cells and motor neurons
#9756MicroRNAs for the generation of astrocytes
#9757Methods of modulating smooth muscle cell proliferation and differentiation
#9758RNA-Mediated Gene Modulation
#9759Compositions and methods for treatment of ovarian cancer
#9760BIOMARKER, USES THEREOF AND THERAPY
#9761Methods and compositions for neuroprotection
#9762Nanoconjugates able to cross the blood-brain barrier
#9763CELL TRANSFECTING FORMULATIONS OF SMALL INTERFERING RNA, RELATED COMPOSITIONS AND METHODS OF MAKING AND USE
#9764RHOGEF12 IS A THERAPEUTIC TARGET FOR THE TREATMENT OF HEART FAILURE
#9765Compounds and methods for enhanced cellular uptake
#9766Promoter and use thereof
#9767Vitamin B6-coupled poly(ester amine) as gene carrier and application in cancer gene therapy
#9768BACTERIAL MEDIATED THF ALPHA GENE SILENCING
#9769METHODS OF TREATING OR PREVENTING VIRAL DISEASES BY BLOCKING INTERLEUKIN-21
#9770Heptamer-type small guide nucleic acids inducing apoptosis of human leukemia cells
#9771COMPOSITIONS AND METHODS FOR MODULATION OF IKBKAP SPLICING
#9772Compositions and methods for the suppression of target polynucleotides from lepidoptera
#9773Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro
#9774COMPOSITIONS AND METHODS FOR TREATING CANCER
#9775Aptamer regulated nucleic acids and uses thereof
#9776NUCLEIC ACID COMPLEX
#9777Targeting RNAs to microvesicles
#9778Pharmaceutical compositions for preventing or treating angiogenic diseases comprising inhibitors of NUP153 gene expression or NUP153 activity as active ingredient
#9779Compositions and methods for diagnosing and treating hyperthyroidism in companion animals
#9780Method for Preparing Fertility-Lowered Plant
#9781Oligomer-conjugate complexes and their use
#9782MODIFIED MIRNA AS A SCAFFOLD FOR SHRNA
#9783Method for promoting angiogenesis, vascularization or vessel repair or for inhibiting tumor angiogenesis
#9784MODULATION OF BREAST CANCER GROWTH BY MODULATION OF XBP1 ACTIVITY
#9785Treatment of disease by modulation of SIRT6
#9786DOUBLE-STRANDED OLIGONUCLEOTIDE COMPOUNDS FOR TREATING HEARING AND BALANCE DISORDERS
#9787Double-stranded and single-stranded RNA molecules with 5′ Triphosphates and their use for inducing interferon
#9788Personalized medicine for the prediction of therapy targeting the hedgehog pathway
#9789BACTERIAL MEDIATED THF ALPHA GENE SILENCING
#9790CARRIER THAT TARGETS FUCOSYLATED MOLECULE-PRODUCING CELLS
#9791DETECTION AND TREATMENT OF METASTATIC DISEASE
#9792Reducing levels of nicotinic alkaloids in plants
#9793NUCLEIC ACID MOLECULE FOR INHIBITING ACTIVITY OF RNAI MOLECULE
#9794Modifications for antisense compounds
#9795METHODS AND COMPOSITIONS FOR TREATING INSECTS
#9796Methods and compositions for panic disorders
#9797Method for enhancing remyelination using GLI1 inhibitors
#9798MicroRNAs for cardiac regeneration through induction of cardiac myocyte proliferation
#9799Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA
#9800Compositions and methods to promote erythropoiesis
#9801Single-Stranded Nucleic Acid Molecule for Controlling Gene Expression
#9802Methods, kits, and systems for treatment of metastatic papillary thyroid cancer
#9803Use of microrna molecules to influence skin pigmentation
#9804CRLF-2 BINDING PEPTIDES, PROTOCELLS AND VIRAL-LIKE PARTICLES USEFUL IN THE TREATMENT OF CANCER, INCLUDING ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
#9805METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
#9806Methods for diagnosing and treating learning or mental disorders
#9807High-efficiency nanoparticle-type double-helical oligo-RNA structure and method for preparing same
#9808Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents
#9809Lipid particle, nucleic acid transfer carrier, compound for manufacturing nucleic acid transfer carrier, method for manufacturing lipid particle, and gene transfer method
#9810Novel shRNA Molecules and Methods of Use Thereof
#9811Methods and compositions involving miRNA and miRNA inhibitor molecules
#9812Modulation of T cell signaling threshold and T cell sensitivity to antigens
#9813METHODS AND COMPOSITIONS FOR INCREASING RNA INTERFERENCE
#9814Simultaneous gene silencing and suppressing gene silencing in the same cell
#9815Transgenic plants modified for reduced cadmium transport, derivative products, and related methods
#9816Transcriptional repression leading to parkinson's disease
#9817MODULATION OF RNA BY REPEAT TARGETING
#9818BIOMARKERS OF MIR-34 ACTIVITY
#9819MODULATION OF EXON RECOGNITION IN PRE-MRNA BY INTERFERING WITH THE SECONDARY RNA STRUCTURE
#9820TREATMENT OF UTERINE LEIOMYOMATA
#9821Novel Antitumor Agent and Method For Screening Same
#9822Pharmaceutical Composition Comprising miRNA-100 And Its Use In The Modulation of Blood Vessel Growth and Endothelial Inflammation
#9823Treatment of vasculoproliferative conditions with Lrg1 antagonists
#9824dsRNA as insect control agent
#9825Method to trigger RNA interference
#9826High efficiency plant expression promoter from serine hydroxymethyl transferase gene and uses thereof
#9827Compositions for RNA interference and methods of use thereof
#9828SINGLE-STRANDED ANTIMICROBIAL OLIGONUCLEOTIDES AND USES THEREOF
#9829NOVEL OLIGONUCLEOTIDE CONJUGATES AND USE THEREOF
#9830Pharmaceutical composition for treating cancer
#9831Use of Apoptosis-Specific elF-5A siRNA to Down Regulate Expression of Proinflammatory Cytokines to Treat Sepsis
#9832Prevention and treatment of Nosema disease in bees
#9833Anti-connexin compounds targeted to connexins and methods of use thereof
#9834Methods for modulating metastasis-associated-in-lung-adenocarcinoma-transcript-1 (MALAT-1) expression
#9835NUCLEIC ACIDS ENCODING PEPTIDES FOR TREATING WOUNDS, ANTI-ANGIOGENIC COMPOUNDS AND USES THEREOF
#9836Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof
#9837RNA interference for the treatment of gain-of-function disorders
#9838INHIBITION OF MACROPHAGE-SYNTHESIZED WNT7B TO INHIBIT TUMOR ANGIOGENESIS AND METASTASIS
#9839Therapeutic nanoparticles and methods of use thereof
#9840Method of expanding hematopoietic stem cells
#9841Methods and compositions for the treatment of cancer
#9842COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS
#9843Reduced size self-delivering RNAi compounds
#9844RNAi-MEDIATED INHIBITION OF IGF1R FOR TREATMENT OF OCULAR ANGIOGENESIS
#9845METHODS, ASSAYS, AND SYSTEMS RELATING TO SAKT
#9846Anti-IL-23 antibodies
#9847CHIMERIC OLIGOMERIC COMPOUNDS COMPRISING ALTERNATING REGIONS OF NORTHERN AND SOUTHERN CONFORMATIONAL GEOMETRY
#9848MODULATION OF EXON RECOGNITION IN PRE-MRNA BY INTERFERING WITH THE SECONDARY RNA STRUCTURE
#9849Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
#9850Means and methods for counteracting, delaying and/or preventing adverse energy metabolism switches in heart disease
#9851MODULATION OF EXON RECOGNITION IN PRE-MRNA BY INTERFERING WITH THE SECONDARY RNA STRUCTURE
#9852Materials and methods related to modulation of mismatch repair and genomic stability by miR-155
#9853RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
#9854Metabolic gene mesenchymal signatures and uses thereof
#9855RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
#9856COMPOSITIONS AND METHODS FOR TREATMENT OF SPINAL MUSCULAR ATROPHY
#9857RADIATION EXPOSURE DIAGNOSTIC MARKER IGFBP-5, COMPOSITION FOR RADIATION EXPOSURE DIAGNOSIS BY MEASURING THE EXPRESSION LEVEL OF THE MARKER, RADIATION EXPOSURE DIAGNOSTIC KIT COMPRISING THE COMPOSITION, AND METHOD FOR DIAGNOSING RADIATION EXPOSURE USING THE MARKER
#9858RNA-guided transcriptional regulation
#9859Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier
#9860Combination therapy to prevent DCIS formation and progression to breast cancer
#9861MATERIALS AND METHODS FOR TREATMENT OF LIVER CANCER
#9862PLOD2 as a Target of Intervention for Sarcoma Metastasis
#9863COMPOSITIONS AND METHODS FOR TREATMENT OF METASTATIC CANCER
#9864SIRNA CONJUGATE AND PREPARATION METHOD THEREOF
#9865siRNA conjugate and preparation method thereof
#9866MicroRNA compounds and methods for modulating miR-122
#9867Methods and compositions involving miRNA and miRNA inhibitor molecules
#9868Sugar alcohol-based compositions for delivering nucleic acid-based drugs in vivo and in vitro
#9869COMPOSITIONS AND METHODS FOR MODULATING ANGIOGENESIS
#9870Genetic Inhibition by Double-Stranded RNA
#9871CONTROLLING REGULATORY T CELL FUNCTION
#9872Amphipathic co-oligomers for the delivery of siRNA
#9873INDUCTION OF EXON SKIPPING IN EUKARYOTIC CELLS
#9874Extended dicer substrate agents and methods for the specific inhibition of gene expression
#9875Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer
#9876Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity
#9877Serapina1 iRNA compositions and methods of use thereof
#9878Methods and agents to increase therapeutic dystrophin expression in muscle
#9879RTP801L SIRNA COMPOUNDS AND METHODS OF USE THEREOF
#9880Antisense molecules and methods for treating pathologies
#9881Self-assembled composite ultrasmall peptide-polymer hydrogels
#9882IN VIVO DELIVERY OF NUCLEIC ACIDS TO THE LIVER OR LIVER TISSUE
#9883METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
#9884Methods and devices for preparation of lipid nanoparticles
#9885RNAi for the control of insects and arachnids
#9886Compositions and methods for treating and preventing neointimal stenosis
#9887IN VIVO DELIVERY OF NUCLEIC ACIDS TO THE LIVER OR LIVER TISSUE
#9888HE4 based therapy for malignant disease
#9889Antisense nucleic acids
#9890Neutral nucleic acid ligands
#9891Gene expression and pain
#9892COMPOSITIONS AND METHODS FOR THE SUPPRESSION OF TARGET POLYNUCLEOTIDES FROM LYGUS
#9893Micro-RNA Scaffolds, Non-naturally Occurring Micro-RNAs, and Methods for Optimizing Non-naturally Occurring Micro-RNAs
#9894MODIFIED NUCLEIC ACIDS, AND ACUTE CARE USES THEREOF
#9895COMPOUNDS FOR THE MODULATION OF SMN2 SPLICING
#9896RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (SINA)
#9897Oligonucleotides for RNA interference and biological applications thereof
#9898Method for reducing expression of downregulated in renal cell carcinoma in malignant gliomas
#9899Conjugated antisense compounds and their use
#9900COMPOSITIONS AND METHODS RELATING TO miR-31